> top > docs > PubMed:19931172 > annotations

PubMed:19931172 JSONTXT

Annnotations TAB JSON ListView MergeView

PubCasesHPO

Id Subject Object Predicate Lexical cue
TI1 20-37 HP:0007687 denotes unilateral ptosis
AB1 154-162 HP:0002665 denotes lymphoma
AB2 168-176 HP:0001909 denotes leukemia
AB3 221-228 HP:0000979 denotes purpura
AB4 233-260 HP:0001890 denotes autoimmune hemolytic anemia
AB5 478-484 HP:0000508 denotes ptosis
AB6 531-559 HP:0006721 denotes acute lymphoblastic leukemia
AB7 561-567 HP:0000508 denotes Ptosis
AB8 720-726 HP:0000508 denotes ptosis
AB9 847-853 HP:0000508 denotes ptosis

PubCasesORDO

Id Subject Object Predicate Lexical cue
AB1 514-559 ORDO:99860 denotes precursor B-cell acute lymphoblastic leukemia

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-49 Sentence denotes Vincristine-induced unilateral ptosis in a child.
TextSentencer_T2 50-261 Sentence denotes Vincristine is a vinca alkaloid used in combination with other agents in the treatment of solid tumors, lymphoma, and leukemia, as well as for idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia.
TextSentencer_T3 262-327 Sentence denotes A dose-limiting complication of vinca alkaloids is neurotoxicity.
TextSentencer_T4 328-403 Sentence denotes Vincristine is the oldest and also the most neurotoxic agent in this group.
TextSentencer_T5 404-485 Sentence denotes Described here is the case of a 4-year-old girl with unilateral palpebral ptosis.
TextSentencer_T6 486-560 Sentence denotes She has been diagnosed with precursor B-cell acute lymphoblastic leukemia.
TextSentencer_T7 561-678 Sentence denotes Ptosis was noted on the 45th day of therapy, and the last vincristine was administered on the 28th day of protocol 1.
TextSentencer_T8 679-746 Sentence denotes Vincristine-induced unilateral palpebral ptosis is a novel finding.
TextSentencer_T9 747-862 Sentence denotes Experience with this case suggests conservative treatment, with periodic examination, especially if ptosis is mild.
T1 0-49 Sentence denotes Vincristine-induced unilateral ptosis in a child.
T2 50-261 Sentence denotes Vincristine is a vinca alkaloid used in combination with other agents in the treatment of solid tumors, lymphoma, and leukemia, as well as for idiopathic thrombocytopenic purpura and autoimmune hemolytic anemia.
T3 262-327 Sentence denotes A dose-limiting complication of vinca alkaloids is neurotoxicity.
T4 328-403 Sentence denotes Vincristine is the oldest and also the most neurotoxic agent in this group.
T5 404-485 Sentence denotes Described here is the case of a 4-year-old girl with unilateral palpebral ptosis.
T6 486-560 Sentence denotes She has been diagnosed with precursor B-cell acute lymphoblastic leukemia.
T7 561-678 Sentence denotes Ptosis was noted on the 45th day of therapy, and the last vincristine was administered on the 28th day of protocol 1.
T8 679-746 Sentence denotes Vincristine-induced unilateral palpebral ptosis is a novel finding.
T9 747-862 Sentence denotes Experience with this case suggests conservative treatment, with periodic examination, especially if ptosis is mild.